Announcements Trials

Browse Landscape

Phase

Status

Terminated 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Melanoma 57 Carcinoma, Renal Cell 19 Leukemia, Myeloid, Acute 15 Lymphoma, Non-Hodgkin 10 Leukemia 10 Kidney Neoplasms 10 Skin Neoplasms 9 Neuroblastoma 9 Neoplasms 9 Neoplasm Metastasis 9 Lymphoma 9 Breast Neoplasms 7 Leukemia, Lymphocytic, Chronic, B-Cell 6 Recurrence 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Ovarian Neoplasms 5 Myelodysplastic Syndromes 5 Congenital Abnormalities 5 Uveal Melanoma 4 Multiple Myeloma 4 Lymphoma, Mantle-Cell 4 Lymphoma, Follicular 4 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4 Hodgkin Disease 4 Hematologic Neoplasms 3 Fallopian Tube Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Carcinoma, Hepatocellular 3 Uterine Cervical Neoplasms 2 Unspecified Adult Solid Tumor, Protocol Specific 2

Interventions

pembrolizumab 3 Ipilimumab 2 Blood Specimen Collection 2 spartalizumab 1 necitumumab 1 mirdametinib 1 leronlimab 1 apatinib 1 Watchful Waiting 1 Tomography, X-Ray Computed 1 Therapeutics 1 Surveys and Questionnaires 1 Rosuvastatin Calcium 1 Radiotherapy 1 Radiation 1 Positron-Emission Tomography 1 PankoMab-GEX 1 Panitumumab 1 Nivolumab 1 Metformin 1 Magnetic Resonance Imaging 1 MEK inhibitor I 1 Jupiter 1 JPT1 protein, human 1 Interleukin-2 1 Immune Checkpoint Inhibitors 1 GAT 1 Fluorodeoxyglucose F18 1 FCN-437c 1 EBI-005 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Solid Tumor, Adult × Interleukin-2 × Clear all

NCT05307874 2025-12-24

EVICTION-2

ImCheck Therapeutics

Phase 1/2 Completed

Other solid neoplasm

Solid Tumor, Adult

Data powered by HemOnc (CC BY 4.0) Colophon ⚡